Medicine details
| Image |  |
| Name | Acilog Pen |
| Dosage | Injection |
| Generic Name | Insulin Aspart |
| Classes |
Antidiabetic Agent Metabolic Agent Insulin |
| Diseases |
Type 2 Diabetes Mellitus Hormonal Disorder |
| Company | ACI Limited |
Drug Package Details
| Strength | 300 IU/3 ml |
| Storage Condition | |
| Origin Country | Bangladesh |
| Commercial Pack | 1 |
| Price per pack | ৳ 450.00 |
| Cost per pack | ৳ 396.00 |
| Package unit | 3 ml vial |
| Price per unit | ৳ 450.00 |
| Cost per unit | ৳ 396.00 |
| Discount | 0 |
| Coupon | |
| Remarks |
Insulin Aspart
NovoLog is a short acting insulin analog. Insulin's main function is to regulate glucose metabolism. Insulin reduces blood glucose levels by boosting skeletal muscle and adipose glucose absorption and blocking hepatic glucose synthesis. Insulins suppress lipolysis, proteolysis, and gluconeogenesis while boosting protein synthesis and fat conversion.
Insulin Aspart is indicated for the control of Diabetes mellitus.
The dosage of NovoLog must be individualized. The total daily insulin requirement may vary and is usually between 0.5 to 1.0 units/kg/day.
- Subcutaneous injection: NovoLog should generally be given immediately (within 5-10 minutes) prior to the start of a meal
- Use in pumps: Change the NovoLog in the reservoir at least every 6 days, change the infusion set, and the infusion set insertion site at least every 3 days. NovoLog should not be mixed with other insulins or with a diluent when it is used in the pump
- Intravenous use: NovoLog should be used at concentrations from 0.05 U/mL to 1.0 U/mL insulin aspart in infusion systems using polypropylene infusion bags. NovoLog has been shown to be stable in infusion fluids such as 0.9% sodium chloride.
Insulin Aspart may cause the following side effects-
- Allergic reactions
- Lipodystrophy
- Pruritus
- Rash
- Hypoglycemia
- Injection site reaction
- Hypoglycemia is the most common adverse effect of insulin therapy. Glucose monitoring is recommended for all patients with diabetes. Any change of insulin dose should be made cautiously and only under medical supervision
- Insulin, particularly when given intravenously or in settings of poor glycemic control, can cause hypokalemia. Use caution in patients predisposed to hypokalemia
- Like all insulins, Insulin Aspart requirements may be reduced in patients with renal impairment or hepatic impairment
- Severe, life-threatening, generalized allergy, including anaphylaxis, may occur with insulin products, including Insulin Aspart
- Fluid retention and heart failure can occur with concomitant use of thiazolidinediones (TZDs), which are PPAR-gamma agonists, and insulin, including Insulin Aspart.
Contraindication
Contraindicated in patients hypersensitive to insulin glulisine or any of its excipients.
None known.
Contraindicated during Hypoglycemia.
Bangla
English